WASHINGTON, Jan. 13, 2017 /PRNewswire-USNewswire/ -- Biologics Prescribers Collaborative (BPC) applauds the U.S. Food and Drug Administration (FDA) for issuing final guidance calling for ...
The agency reiterated its earlier decision to require suffixes in biosimilar naming, but was unclear on suffix meaning. A Federal Register notice from FDA addressed comments on the guidance on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback